FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On March 13, 2006
Table of Contents
Docket # Title
1975N-0183H Health-Care Antiseptic Drug Products for OTC Human Use
1990S-0308 Generic Drug Speeches & Policy and Procedure Guides
1991F-0457 Safe use of Glycerides and Polyethylene Glycol Esters
1999P-1340 Declared Eternity eau de Parfum Misbranded
2001P-0345 Listing the color additive yellow #5 for use in food/Drug
2002D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
2002P-0317 Recall Aspartame as a Neurotoxic Drug
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2004P-0512 Health Claim Petition for Soluble Fiber from Barley
2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
2005N-0471 Immunology and Microbiology Devices: Reclassification of Herpes Simplex Virus (Types 1 and/or 2) Serological Assays
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
1975N-0183H Health-Care Antiseptic Drug Products for OTC Human Use
EMC 13
Attachment
BODE Chemie GmbH & Co. Vol #: 200
1990S-0308 Generic Drug Speeches & Policy and Procedure Guides
RPT 764 Statistical Report - Month of February 2006 Vol #: 55
1991F-0457 Safe use of Glycerides and Polyethylene Glycol Esters
BKG 1 Background Information Vol #: 1
EA 1 Environmental Assessment Vol #: 1
FONS 1 Finding of No Significant Impact Vol #: 1
NFR 1 FDA Vol #: 1
SUP 1 FDA/CFSAN Vol #: 1
SUP 2 American Clinical Research Consultants Inc. Vol #: 1
1999P-1340 Declared Eternity eau de Parfum Misbranded
EMC 631 B. Alonge Vol #: 24
2001P-0345 Listing the color additive yellow #5 for use in food/Drug
EMC 1312 No signature Vol #: 6
EMC 1313 C. Fredrickson Vol #: 6
2002D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
EMC 241 C. Meissner Vol #: 4
2002P-0317 Recall Aspartame as a Neurotoxic Drug
EMC 612 Mission Possible International Vol #: 9
EMC 613 Mission Possible International Vol #: 9
EMC 614 Mission Possible International Vol #: 9
EMC 615 Calorie Control Council Vol #: 9
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EMC 1244 C. Munday Vol #: 12
EMC 1245 V. Gillespie Vol #: 12
EMC 1246 T. Fulton Vol #: 12
EMC 1247 P. Rambo Vol #: 12
EMC 1248 L. Setliffe Vol #: 12
EMC 1249 B. Vandeman Vol #: 12
EMC 1250 R. Bush Vol #: 12
2004P-0512 Health Claim Petition for Soluble Fiber from Barley
M 1 HFS-832 Vol #: 10
2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
EMC 564 I. Brothers Vol #: 12
EMC 565 Merck & Co., Inc. Vol #: 12
EMC 566 J. Buckley, R.Ph., MBA Vol #: 12
EMC 567 S. Hauser Vol #: 12
EMC 568 K. Harrod Vol #: 12
EMC 569 A. Meissner Vol #: 12
EMC 570 S. Fitzpatrick Vol #: 12
EMC 571 L. Scoccia Vol #: 12
EMC 572 A. Piard Vol #: 12
EMC 573 J. Parker Vol #: 12
EMC 574 D. Zaviska Vol #: 12
EMC 575 J. Mark Vol #: 12
EMC 576 C. Stephens Vol #: 12
EMC 577 J. Wilson Vol #: 12
EMC 578 P. Rosnel Vol #: 12
EMC 579 E. Isley Vol #: 12
EMC 580 G. Holzer Vol #: 12
EMC 581 A. Mauhs Vol #: 12
EMC 582 A. Brinkman Vol #: 12
EMC 583 D. Lopez, RN Vol #: 12
EMC 584 B. Vuckovic Vol #: 12
EMC 585 M. McElhaney Vol #: 12
EMC 586 J. Raymond Vol #: 12
EMC 587 T. Brathwaite Vol #: 12
EMC 588 M. Kalas Vol #: 12
2005N-0471 Immunology and Microbiology Devices: Reclassification of Herpes Simplex Virus (Types 1 and/or 2) Serological Assays
NCR 1 FDA Vol #: 1
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
EMC 27 M. Heltsley Vol #: 39
EMC 28 M. Rhyne Vol #: 39
EMC 29 R. Falk Vol #: 39
EMC 30 B. Cunningham Vol #: 39
EMC 31 S. Davis Vol #: 39
EMC 32 D. Lippert Vol #: 39
EMC 33 No signature Vol #: 39
EMC 34 P. Holyk Vol #: 39
EMC 35 V. Cleek Vol #: 39
EMC 36 P. Pedersen Vol #: 39
EMC 37 C. Ekstedt Vol #: 39
EMC 38 R. Morrison Vol #: 39
EMC 39 B. Smallwood Vol #: 39
EMC 40 T. Simpson Vol #: 39
EMC 41 M. Campbell Vol #: 39
EMC 42 L. Butz Vol #: 39
EMC 43 C. Wright Vol #: 39
EMC 44 W. Creatore Vol #: 39
EMC 45 Yda M.R. Vol #: 39
EMC 46 B. Gardner Vol #: 39
EMC 47 R. McDonald Vol #: 39
EMC 48 S. Kuethe Vol #: 39
EMC 49 S. Intilli Vol #: 39
EMC 50 T. Lyman Vol #: 39
EMC 51 W. Teague Vol #: 39
EMC 52 W. Cone Vol #: 39
EMC 53 E. Frieder Vol #: 39
EMC 54 L. Wolf Vol #: 39
EMC 55 L. Perry Vol #: 39
EMC 56 K. Miller Vol #: 39
EMC 57 K. Miller Vol #: 39
EMC 58 C. Dute Vol #: 39
EMC 59 V. Serorian Vol #: 39
EMC 60 S. Ross Vol #: 39
EMC 61 B. Bielema Vol #: 39
EMC 62 G. Shufelt Vol #: 39
EMC 63 D. Trojan Vol #: 39
EMC 64 D. Waldman Vol #: 39
EMC 65 S. Bennett Vol #: 39
EMC 66 D. Lauren Vol #: 39
EMC 67 J. Engelmann Vol #: 39
EMC 68 J. Yeagley Vol #: 39
EMC 69 J. Keogh Vol #: 39
EMC 70 D. Keudell Vol #: 39
EMC 71 C. Beaver Vol #: 39
EMC 72 K. Mills Vol #: 39
EMC 73 S. Dellerson Vol #: 39
EMC 74 D. Turner Vol #: 39
EMC 75 R. Zeidler Vol #: 39
EMC 76 P. Stickney Vol #: 39
EMC 77 N. Miller Vol #: 39
EMC 78 K. Walsh Vol #: 39
EMC 79 S. Reischman Vol #: 39
EMC 80 J. Graham Vol #: 39
EMC 81 C. Dohrenwend Vol #: 39
EMC 82 J. Oliphant Vol #: 39
EMC 83 M. Frederiksen Vol #: 39
EMC 84 R. Plemmons Vol #: 39
EMC 85 R. Newman Vol #: 39
EMC 86 R. Mayfield Vol #: 39
EMC 87 M. Hance Vol #: 39
EMC 88 V. Wells Vol #: 39
EMC 89 L. Thurman Vol #: 39
EMC 90 R. Aragona Vol #: 39
EMC 91 D. Monico Vol #: 39
EMC 92 L. Hammer Vol #: 39
EMC 93 M. Halligan Vol #: 39
EMC 94 A. Gronstedt Vol #: 39
EMC 95 M. Dzindzeleta Vol #: 39
EMC 96 E. Fry Vol #: 39
EMC 97 D. Selover Vol #: 39
EMC 98 C. Stauber Vol #: 39
EMC 99 L. Hartwick Vol #: 39
EMC 100 J. Humiston Vol #: 39
EMC 101 H. Tennyson Vol #: 39
EMC 102 J. Skardis Vol #: 39
EMC 103 M. Vaine Vol #: 39
EMC 104 K. Stafford Vol #: 39
EMC 105 R. Turrou Vol #: 39
EMC 106 V. Magown Vol #: 39
EMC 107 N. Michelli Vol #: 39
EMC 108 M. Reeves Vol #: 39
EMC 109 M. Burger Vol #: 39
EMC 110 M. Miller Vol #: 39
EMC 111 L. Odom Vol #: 39
EMC 112 C. Horkin Vol #: 39
EMC 113 B. Potter Vol #: 39
EMC 114 W. Venturella Vol #: 39
EMC 115 M. Lawson Vol #: 39
EMC 116 S. Oliver Vol #: 39
EMC 117 R. Renfield Vol #: 39
EMC 118 C. Taranova Vol #: 39
EMC 119 B. Stone Vol #: 39
EMC 120 B. Gonsalves Vol #: 39
EMC 121 N. Ingram Vol #: 39
EMC 122 L. Flagler Vol #: 39
EMC 123 N. Faass Vol #: 39
EMC 124 S. Deemer Vol #: 39
EMC 125 D. Hummel Vol #: 39
EMC 126 E. Cole Vol #: 39
EMC 127 A. Flores Vol #: 39
EMC 128 A. Hathaway Vol #: 39
EMC 129 B. Hatzenbuehler Vol #: 39
EMC 130 C. Beck Vol #: 39
EMC 131 P. Vogel Vol #: 39

Page created on April 6, 2006 RSC

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management